Reducing the burden of migraine: safety and efficacy of cgrp pathway-targeted preventive treatments

HIGHLIGHTS

• who: George R. Nissan and colleagues from the North Texas Institute of Neurology and Headache, Plano, TX, USA Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH, USA have published the research: Reducing the Burden of Migraine: Safety and Efficacy of CGRP Pathway-Targeted Preventive Treatments, in the Journal: (JOURNAL)
• what: The authors provide a brief introduction to targeting the calcitonin gene-related peptide (CGRP) pathway as a therapeutic approach in migraine preventive therapy, followed by an update of clinical data for CGRP pathway targeted monoclonal antibody therapies for migraine prevention, including . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.